An immuno-dot blot assay for screening histidine kinase inhibitors.


Journal

Analytical biochemistry
ISSN: 1096-0309
Titre abrégé: Anal Biochem
Pays: United States
ID NLM: 0370535

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 09 03 2020
revised: 26 04 2020
accepted: 27 04 2020
pubmed: 4 5 2020
medline: 20 1 2021
entrez: 4 5 2020
Statut: ppublish

Résumé

Two-component signal transduction systems (TCSs), consisting of a histidine kinase (HK) and its cognate response regulator, are ubiquitous among bacteria and are associated with the virulence of pathogens. TCSs are potential targets for alternative antibiotics and antivirulence agents. It is, thus, very important to determine HK activity in bacterial TCSs. Here, we describe an immuno-dot blot assay for the inhibition profiling of HKs using the anti-N3-phosphohistidine antibody. This simple method promises reliable detection of HK activity, and it is likely applicable in high-throughput screening of HK inhibitors.

Identifiants

pubmed: 32360198
pii: S0003-2697(20)30297-9
doi: 10.1016/j.ab.2020.113765
pii:
doi:

Substances chimiques

Protein Kinase Inhibitors 0
Quinones 0
waldiomycin 0
Histidine Kinase EC 2.7.13.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

113765

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Emiko Kinoshita-Kikuta (E)

Department of Functional Molecular Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Shino Maruta (S)

Department of Functional Molecular Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Yoko Eguchi (Y)

Department of Science and Technology on Food Safety, Faculty of Biology-Oriented Science and Technology, Kindai University, Wakayama, Japan.

Masayuki Igarashi (M)

Institute of Microbial Chemistry, Tokyo, Japan.

Toshihide Okajima (T)

Department of Biomolecular Science and Reaction, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Ryutaro Utsumi (R)

Department of Biomolecular Science and Reaction, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan.

Eiji Kinoshita (E)

Department of Functional Molecular Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan. Electronic address: kinoeiji@hiroshima-u.ac.jp.

Tohru Koike (T)

Department of Functional Molecular Science, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Humans Melanoma Skin Neoplasms Antineoplastic Combined Chemotherapy Protocols Randomized Controlled Trials as Topic
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin

Classifications MeSH